Aer Therapeutics to Participate at Cantor Global Healthcare Conference GlobeNewswire August 27, 2025 DURHAM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) — Aer Therapeutics (“Aer”), a biopharmaceutical company developing novel inhaled treatments for mucus-associated lung disease, announced today that Thomas P. Mathers, Executive Chairman of Aer, will participate in 1×1 investor meetings at the Cantor Global […]
nCino to Participate in Upcoming Investor Events GlobeNewswire August 27, 2025 WILMINGTON, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced its participation in the following investor conferences: Goldman Sachs Communacopia + Technology Conference 2025Presentation: Wednesday September 10, at 2:25 p.m. PT (5:25
NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 17th, 2025 GlobeNewswire August 27, 2025 MONTREAL, Aug. 27, 2025 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore“) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its fourth quarter and year end results ended
Bread Financial Announces Approval of $200 Million Share Repurchase Program GlobeNewswire August 27, 2025 COLUMBUS, Ohio, Aug. 27, 2025 (GLOBE NEWSWIRE) — Bread Financial(R) Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) today announced that its Board of Directors (the “Board”) has authorized a new plan to repurchase up to $200 million of shares
Bancroft Fund Ltd. Declares Distribution of $0.32 per Share GlobeNewswire August 27, 2025 RYE, N.Y., Aug. 27, 2025 (GLOBE NEWSWIRE) — The Board of Trustees of Bancroft Fund Ltd. (NYSE American: BCV) (the “Fund”) declared a $0.32 per share cash distribution payable on September 23, 2025 to common shareholders of record on September 16, 2025.
Dyne Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire August 27, 2025 WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:
NEW YORK, NY / ACCESS Newswire / August 27, 2025 / If you suffered a loss on your PubMatic, Inc. (NASDAQ:PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=163865&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 27, 2025 / If you suffered a loss on your C3.ai, Inc. (NYSE:AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=163864&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 27, 2025 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=163873&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 27, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=163872&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or